AGP Executive Report
Last update: 12 hours agoRegulatory Shock: CMS is piloting Medicare/Medicaid reimbursement for hemp-derived products (including CBD) up to $500/year, but a looming federal “hemp ban” tied to the spending bill could criminalize many products by Nov. 12, putting the program in jeopardy. Legal & Policy Pressure: Ohio’s THC crackdown fallout is still rippling—businesses warn the state changed rules after they invested in intoxicating hemp products. Enforcement Escalation: Nigeria’s NDLEA says it intercepted cocaine and opioids hidden in carton walls bound for the UK and Australia, while also destroying 65,000kg of skunk in Delta. US Courts Watch: The Supreme Court paused a far-right 5th Circuit move affecting mail/telemedicine access to mifepristone—another sign of how quickly legal outcomes can shift. State-Level Momentum: Indiana Republicans are increasingly open to medical marijuana, with a senator signaling a 2027 legalization proposal.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
